First-line systemic therapy for HER2-positive metastatic breast cancer in pertuzumab era

Mariko Sato

[P66-9] First-line systemic therapy for HER2-positive metastatic breast cancer in pertuzumab era

^○Mariko Sato¹, Sugiyama Keiji¹, Shiraishi Kazuhiro¹, Nishibori Riko¹, Kato Kyoko¹, Funahashi Yoriko¹, Kato Aya², Hayashi Takako², Morita Takako², Kitagawa Chiyoe¹ (1.Department of Medical Oncology, NHO Nagoya Medical Center, 2.Department of Breast Surgery, NHO Nagoya Medical Center)

Abstract password authentication.
The password can be found on page 27 of the program book.

Presentation information

[P66] Poster Session 66　Breast Cancer（Metastatic）

[P66-9] First-line systemic therapy for HER2-positive metastatic breast cancer in pertuzumab era

Password

Presentation information

[P66] Poster Session 66 Breast Cancer（Metastatic）

[P66-9] First-line systemic therapy for HER2-positive metastatic breast cancer in pertuzumab era

Password

[P66] Poster Session 66　Breast Cancer（Metastatic）